Etesevimab
Showing 1 - 7 of 7
Covid19 Trial in Pittsburgh (Lilly Bamlanivimab, Regeneron Casirivimab + Imdevimab, Lilly Bamlanivimab + Etesevimab)
Completed
- Covid19
- Lilly Bamlanivimab
- +4 more
-
Pittsburgh, PennsylvaniaUPMC
Jun 16, 2022
Healthy Trial in Daytona Beach (LY3832479, Placebo)
Completed
- Healthy
- LY3832479
- Placebo
-
Daytona Beach, FloridaCovance Clinical Research Inc
Nov 1, 2021
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies
Recruiting
- Immunocompromised Patients
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
COVID-19 Complications in High-risk Subjects Infected by
Recruiting
- SARS-CoV Infection
- Covid19
- biobank
-
Agen, France
- +36 more
Apr 6, 2022
TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use
Recruiting
- COVID-19
- casirivimab with imdevimab
- +2 more
-
Amsterdam, Noord Holland, Netherlands
- +3 more
Jan 13, 2022